ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,059,000 | +65.5% | 22,148 | +6.1% | 0.00% | +33.3% |
Q3 2021 | $1,244,000 | -31.9% | 20,882 | -22.0% | 0.00% | -40.0% |
Q2 2021 | $1,826,000 | +10.2% | 26,771 | +12.1% | 0.01% | 0.0% |
Q1 2021 | $1,657,000 | -1.3% | 23,880 | +9.3% | 0.01% | -16.7% |
Q4 2020 | $1,679,000 | +36.7% | 21,856 | +33.1% | 0.01% | 0.0% |
Q3 2020 | $1,228,000 | +17.7% | 16,419 | -0.9% | 0.01% | 0.0% |
Q2 2020 | $1,043,000 | +151.9% | 16,566 | +68.2% | 0.01% | +100.0% |
Q1 2020 | $414,000 | -48.4% | 9,850 | -44.3% | 0.00% | -25.0% |
Q4 2019 | $803,000 | -8.5% | 17,681 | -7.8% | 0.00% | -20.0% |
Q3 2019 | $878,000 | -24.0% | 19,177 | -2.8% | 0.01% | -28.6% |
Q2 2019 | $1,156,000 | +16.2% | 19,724 | -11.1% | 0.01% | +16.7% |
Q1 2019 | $995,000 | +16.4% | 22,199 | +1.1% | 0.01% | 0.0% |
Q4 2018 | $855,000 | -29.1% | 21,961 | -16.2% | 0.01% | -25.0% |
Q3 2018 | $1,206,000 | +1.6% | 26,199 | -3.8% | 0.01% | 0.0% |
Q2 2018 | $1,187,000 | +23.8% | 27,231 | +12.2% | 0.01% | +33.3% |
Q1 2018 | $959,000 | +4.6% | 24,272 | -10.1% | 0.01% | 0.0% |
Q4 2017 | $917,000 | +45.1% | 26,989 | +8.9% | 0.01% | 0.0% |
Q3 2017 | $632,000 | +95.7% | 24,793 | +29.6% | 0.01% | +100.0% |
Q2 2017 | $323,000 | – | 19,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |